By targeting the GI pathway, Gelesis has the potential to transform how related chronic diseases are treated.

*Future investment and timing with respect to our pipeline candidates is contingent on the timing and magnitude of additional fundraising.

*Future investment and timing with respect to our pipeline candidates is contingent on the timing and magnitude of additional fundraising.

PLENITY®

now FDA Cleared 

Stay up to date with Gelesis innovations